Cargando…
Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers
Anticancer drugs in monotherapy are ineffective to treat various kinds of cancer due to the heterogeneous nature of cancer. Moreover, available anticancer drugs possessed various hurdles, such as drug resistance, insensitivity of cancer cells to drugs, adverse effects and patient inconveniences. Hen...
Autores principales: | Kumar, Girish, Virmani, Tarun, Sharma, Ashwani, Pathak, Kamla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055866/ https://www.ncbi.nlm.nih.gov/pubmed/36986748 http://dx.doi.org/10.3390/pharmaceutics15030889 |
Ejemplares similares
-
Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine
por: Sharma, Ashwani, et al.
Publicado: (2022) -
Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy
por: Yang, Yu-Ling, et al.
Publicado: (2021) -
Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance
por: Sharma, Ashwani, et al.
Publicado: (2022) -
Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies
por: Kumar, Mahesh, et al.
Publicado: (2023) -
Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates
por: Virmani, Tarun, et al.
Publicado: (2023)